[PH2B-[CH2PPH2-(2)]]-PD-[N,C:ETA2-N-IPR2CHCH3]
Compound with spectra: 2 NMR
![[PH2B-[CH2PPH2-(2)]]-PD-[N,C:ETA2-N-IPR2CHCH3]](/api/compound/JQZokCPxGly.png?ph=true&h=300&w=458 "[PH2B-[CH2PPH2-(2)]]-PD-[N,C:ETA2-N-IPR2CHCH3]")
| SpectraBase Compound ID | JQZokCPxGly |
|---|---|
| InChI | InChI=1S/C38H34BP2.C8H18N.Pd/c1-7-19-33(20-8-1)39(34-21-9-2-10-22-34,31-40(35-23-11-3-12-24-35)36-25-13-4-14-26-36)32-41(37-27-15-5-16-28-37)38-29-17-6-18-30-38;1-6-9(7(2)3)8(4)5;/h1-30H,31-32H2;6-8H,1-5H3;/q-1;;-1/p+2 |
| InChIKey | JPJIACISCQRLDN-UHFFFAOYSA-P |
| Mol Weight | 800.1 g/mol |
| Molecular Formula | C46H54BNP2Pd |
| Exact Mass | 799.285935 g/mol |
| Parent InChIKey | MIEFOQYANUAIRH-UHFFFAOYSA-P |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
HAMIGERAN-B
Cholesterol <7.alpha.,25-dihydroxy->, tri-TMS
Ethyl 3-azido-2-(7-benzyloxy-3-methyl-1-phenylsulphonyl-1H-indol-4-yl)propenoate
[(3S,7R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-3-trimethylsilyloxy-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-7-yl]oxy-trimethyl-silane
Silane, [[(3.beta.,7.beta.)-cholest-5-ene-3,7-diyl]bis(oxy)]bis[trimethyl-
11,11-DIFLUORO-5,7-PERI-NAPHTHALENO-1,6-METHANO-[10]-ANNULENE
4-Propyl-1,5,5-trimethyl-8-oxatetracyclo[8.3.1.0(2,7).0(7,14)]tetradecan-3-one
tert-Butyl 4-[2,2-Di-tert-butyl-4-(3,5-dioxohexanoyl)-naphtho[1,8-de][1,3,2]dioxasilin-5-yl]-3-oxobutanoate
1-[(3-chloro-6-nitro-1-benzothien-2-yl)carbonyl]-6-ethoxy-2,2,4-trimethyl-1,2-dihydroquinoline
N-Phenyl-8-oxo-9-(p-tolyl)-4,5,6,7,8,9-hexahydropyrazolo[5,1-b]-quinazoline-3-carboxamide
| Title | Journal or Book | Year |
|---|---|---|
| Synthetic, Structural, and Mechanistic Aspects of an Amine Activation Process Mediated at a Zwitterionic Pd(II) Center | Journal of the American Chemical Society | 2004 |